Services & Alliances

Tempo Bioscience (Tempo) develops cutting-edge 2D&3D human cellular technologies to serve the needs of a variety of preclinical research & drug development pipelines across unique and diverse therapeutic and diagnostic areas. Tempo offers services and alliances based on our advanced technological platforms and a range of capabilities. Our team differentiates ourselves based on a strong commitment to innovative solutions and quality R&D for our partners.

 

Our clients include some of the world's leading research institutions, venture-backed biotech startups, and Fortune 500 companies. Our alliances fall under the following categories:

  • Patient relevant stem cell based models to support drug discovery, preclinical studies, and early-stage clinical development.
  • Phenotypic cell based assay systems for preclinical validation studies.
  • Target based assay systems for preclinical validation studies.
  • Stem cell biobanking and biomarker development.
  • 3D Spheroid and Organoid models.
  • In vitro toxicology evaluations (e.g., cardiotoxicity, neurotoxicity, nephrotoxicity, and mitochondrial toxicity).

Please contact Tempo Bioscience Support Team to receive a PDF copy of:

  • poster #P2.22 presented at the Cell Symposia 2016
  • poster #P1047 presented at the SLAS2015
  • editorial article published by IPI (Summer 2018 Volume 10 Issue 2)
  • poster #30 at the CHI's World Preclinical Congress Europe 2018

For technical brochures and a list of Tempo Bioscience product citations, please send requests to Tempo Bioscience Support Team